MOORE CAPITAL MANAGEMENT, LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$676,000
-82.0%
19,501
-77.6%
0.02%
-58.5%
Q4 2020$3,764,000
-38.9%
86,915
-22.2%
0.04%
-65.3%
Q3 2020$6,162,000
+468.5%
111,745
+49.0%
0.12%
+237.1%
Q4 2016$1,084,000
-16.2%
75,000
+87.5%
0.04%
-12.5%
Q4 2015$1,293,00040,0000.04%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders